Otros idiomas Relay Therapeutics, Inc.

Acciones

RLAY

US75943R1023

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 27/06/2024			Varia. Cinco días.	Varia. 1 de enero.
6,3 ^USD	+0,64 %		-8,03 %	-42,78 %

12/06	Transcript : Relay Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM
06/06	Transcript : Relay Therapeutics, Inc. - Special Call

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Relay Therapeutics Discloses Three New Programs at New Program and Platform Event	07/06
Relay Therapeutics : June 2024 Corporate Presentation	06/06
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event	06/06
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event	06/06
Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment	05/06
Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment	05/06
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608	05/06
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608	05/06
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with Rly-2608	05/06
Relay Therapeutics to Participate in Upcoming Investor Conferences	21/05
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024	13/05
Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q1 Revenue $10M	02/05
Relay Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights	02/05
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024	25/04
Relay Therapeutics to Participate in Upcoming Investor Conferences	11/04
Relay Therapeutics to Participate in Three Upcoming Investor Conferences	26/02
Relay Therapeutics Q4 Loss Widens, Reports No Revenue	23/02
Relay Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Relay Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Relay Therapeutics, Inc.

Acciones

RLAY

US75943R1023

Otros idiomas

Filtros